Text Size
42 studies found for:    " March 02, 2011":" April 01, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Grade I Lymphomatoid Granulomatosis;   Recurrent Grade II Lymphomatoid Granulomatosis;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Multiple Myeloma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bendamustine hydrochloride;   Drug: veliparib;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Biological: rituximab
22 Recruiting Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
Conditions: HIV-1 Infection;   Kaposi's Sarcoma
Interventions: Drug: efavirenz/emtricitabine/tenofovir disoproxil fumarate;   Drug: etoposide
23 Recruiting HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women
Condition: HIV-1 Infection
Interventions: Procedure: cervical cryotherapy;   Procedure: Loop Electrosurgical Excision Procedure (LEEP)
24 Unknown † Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
25 Completed Managerial Database II
Condition: Acquired Immunodeficiency Syndrome
Intervention:
26 Active, not recruiting A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
27 Active, not recruiting Neighborhoods, Networks, Depression, and HIV Risk
Conditions: HIV;   Depression;   Drug Use
Interventions: Behavioral: Workshop;   Behavioral: Workshop control
28 Recruiting A Methadone Maintenance Treatment Outcome Study in Three Provinces in China
Conditions: HIV;   Hepatitis C;   Syphilis;   Herpes Simplex Type II
Interventions: Behavioral: MMT provider dosage training;   Behavioral: targeted counseling;   Other: national guidelines
29 Recruiting Behavioral Science Aspects of Rapid Test Acceptance
Conditions: HIV;   Hepatitis C;   Hepatitis B;   Syphilis
Interventions: Device: Rapid tests for HIV, HCV, HBV, and syphilis;   Device: HIV/HCV;   Device: HIV/syphilis;   Device: HIV only
30 Active, not recruiting A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Conditions: HIV Coinfection;   Hepatitis C;   Hepatitis B;   Hepatotoxicity
Interventions: Drug: Maraviroc;   Drug: Placebo
31 Enrolling by invitation Kaiser Permanente HIV Cohort Study
Conditions: HIV;   AIDS
Intervention:
32 Enrolling by invitation HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University
Conditions: HIV;   AIDS
Intervention:
33 Recruiting The Raltegravir 60+ Study
Condition: HIV
Intervention: Drug: Raltegravir
34 Recruiting Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
Conditions: HIV;   Lymphoma
Intervention:
35 Recruiting Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Conditions: Hazardous Drinking;   HIV
Intervention: Behavioral: Brief alcohol intervention
36 Completed Drug Interactions Between Echinacea Purpurea and Etravirine
Condition: HIV
Intervention: Dietary Supplement: Echinacea purpurea
37 Not yet recruiting The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study
Condition: HIV
Intervention: Drug: Maraviroc
38 Completed Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine
Condition: HIV
Interventions: Biological: Investigational HIV vaccine dose A;   Biological: Investigational HIV vaccine dose B
39 Recruiting Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users
Conditions: HIV;   AIDS
Intervention: Behavioral: individualized Texting for Adherence Building (iTAB)
40 Recruiting Levels of Raltegravir in the Female Genital Tissue
Condition: HIV
Intervention: Drug: Raltegravir
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
† Indicates status has not been verified in more than two years